Inhibitors of Sphingolipid Metabolism
A85392 (R)-FTY720-OMe
Buy nowA85393 THI
Buy nowA85494 GT-11
Buy nowA86455 N-C12-deoxysphingosine
Buy nowA86456 N-C16-deoxysphingosine
Buy nowA86461 N-C12-desoxymethylsphinganine
Buy nowA86466 N-C12-desoxymethylsphingosine
Buy nowA86462 N-C16-deoxysphinganine
Buy nowA86463 N-C16-desoxymethylsphinganine
Buy nowA86467 N-C16-desoxymethylsphingosine
Buy nowA86464 N-C24:1-deoxysphinganine
Buy nowA86457 N-C24:1-deoxysphingosine
Buy nowA86465 N-C24:1-desoxymethylsphinganine
Buy nowA86468 N-C24:1-desoxymethylsphingosine
Buy nowA86493 1-deoxysphinganine
Buy nowA86470 1-deoxysphingosine
Buy nowA86473 1-desoxymethylsphinganine
Buy nowA86477 1-desoxymethylsphingosine
Buy nowA86479 Adamantanyl Galactosyl(ß) Ceramide
Buy nowA86480 C10 bisphosphonate
Buy nowA86488 Safingol
Buy nowA86771 Enigmol(2S,3S,5S)
Buy nowA86772 N-C6-Enigmol(2S,3S,5S)
Buy nowA86792 C23 Galactosyl(ß) Ceramide (d18:1/23:0)
Buy nowLewis, A.C., Wallington-Beddoe, C.T., Powell, J.A., et al. Targeting sphingolipid metabolism as an approach for combination therapies in hematological malignancies. Cell Death Discov. 4, 72 (2018). https://doi.org/10.1038/s41420-018-0075-0